roxadustat anemia of CKD
Selected indexed studies
- Cardiovascular Safety of Roxadustat in CKD Anemia: A Fig Leaf Named Noninferiority. (Clin J Am Soc Nephrol, 2021) [PMID:34362784]
- Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study. (J Am Soc Nephrol, 2021) [PMID:33568383]
- Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non-Dialysis-Dependent CKD-Associated Anemia. (Kidney Int Rep, 2025) [PMID:40303227]
_Worker-drafted node — pending editorial review._
Connections
roxadustat anemia of CKD is a side effect of
Sources
- Cardiovascular Safety of Roxadustat in CKD Anemia: A Fig Leaf Named Noninferiority. (2021) pubmed
- Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study. (2021) pubmed
- Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non-Dialysis-Dependent CKD-Associated Anemia. (2025) pubmed
- Efficacy of Roxadustat in Anemia with Chronic Kidney Disease. (2025) pubmed
- Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study. (2022) pubmed
- Treatment of Renal Anemia with Roxadustat: Advantages and Achievement. (2020) pubmed
- The role of roxadustat in chronic kidney disease patients complicated with anemia. (2023) pubmed
- A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat. (2017) pubmed
- Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia. (2023) pubmed
- Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis. (2021) pubmed